Cell Culture Medium Trace Elements Control C-Terminal Heterogeneity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge in producing recombinant therapeutic proteins is to control post-translational modifications, particularly C-terminal heterogeneity, which affects the quality, yield, and immunogenicity of polypeptides, as existing methods struggle to maintain consistent C-terminal α-amidation and C-terminal lysine levels during protein production.
Innovation Solution
Incorporating specific concentrations of essential trace elements like selenium and zinc into the cell culture medium to modulate the activity of peptidylglycine α-amidating monooxygenase (PAM) and carboxypeptidase (CP) enzymes, thereby controlling C-terminal α-amidation and C-terminal cleavage of amino acid residues in polypeptides.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If post-translational modifications are allowed to occur naturally during protein production, then the polypeptides exhibit biological activity and proper folding, but C-terminal heterogeneity increases leading to product quality inconsistency
Solution Approach 1:
The patent changes the chemical parameters of the culture medium by adding specific inhibitors (e.g., N-acetylcysteine, N-ethylmaleimide) that modify the redox environment and inhibit disulfide bond formation. This parameter change prevents C-terminal α-amidation and lysine cleavage, thereby reducing C-terminal heterogeneity and improving product quality consistency while maintaining protein functionality
2Manufacturing precision
If C-terminal α-amidation is reduced through inhibitor addition, then C-terminal heterogeneity decreases and product quality improves, but the complexity of the production process increases
Solution Approach 1:
The patent modifies the chemical environment by adding specific inhibitors to the culture medium at defined concentrations and time points. This approach achieves precise control over C-terminal modifications through simple parameter adjustments rather than complex process changes, maintaining manufacturing precision while minimizing process complexity
Solution Approach 2:
The patent uses small molecule inhibitors as intermediary substances that mediate between the cellular enzymatic systems and the final protein product. These inhibitors selectively block specific post-translational modifications without affecting overall protein synthesis or folding, providing precise control with minimal process complexity
3Manufacturing precision
If trace elements like selenium and zinc are added to control enzyme activity, then C-terminal modification control improves, but the cost of production increases
Solution Approach 1:
The patent optimizes the concentration of trace elements in the culture medium to achieve effective control of C-terminal modifications at minimal costs. By carefully selecting and adjusting trace element concentrations, the patent achieves precise manufacturing control while minimizing the quantity of expensive substances required
Solution Approach 2:
The patent utilizes naturally occurring trace elements (selenium, zinc) that are already present in the culture medium at low concentrations. These elements serve dual purposes: supporting cell growth and providing endogenous control over enzyme activity. This self-service approach reduces production costs by leveraging existing medium components rather than requiring additional expensive additives
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the production of non-immunogenic polypeptides with reduced C-terminal α-amidation and increased C-terminal lysine levels, enhancing product quality and stability, while maintaining acceptable cell growth and productivity.
Implementation Method 1
Incorporating specific concentrations of essential trace elements like selenium and zinc into the cell culture medium to modulate the activity of peptidylglycine α-amidating monooxygenase (PAM) and carboxypeptidase (CP) enzymes
Data Source
AI summary
The present invention is related to a cell culture medium for reducing the C-terminal heterogeneity of a polypeptide expressed in cell-culture, wherein the medium comprises at least one essential trace element in an effective amount, and to a cell culture process for reducing C-terminal heterogeneity of a protein, in which process an essential trace element is used.